Compound that aids in the digestion of fatty foods within the intestine demonstrates potential as a treatment for a rare brain disorder

In a work, recently published in the Journal of Clinical Investigation, researchers at the Life and Health Science Research Institute (ICVS) at the University of Minho, in Portugal, used animal models of spinocerebellar ataxia type 3 or Machado-Joseph disease (SCA3/MJD) to test a promising drug: the compound tauroursodeoxycholic acid (TUDCA for short).

Read More